Concepedia
Statistics
Publications
6
Citations
888
H-Index
Active since
2000
Affiliations
Moffitt Cancer Center(Current)
University of South Florida
Sylvie Wittmann is an author at Moffitt Cancer Center specializing in apoptosis, life sciences, and pharmacology.
Publications per year
2000–2004
Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B.
Lianne Fuino, Purva Bali, Sylvie Wittmann et al. · PubMed · 2003 · 261 citations
Life Sciences, Molecular Biology, Oncology +17
CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl–positive human leukemia cells to apoptosis due to antileukemic drugs
Guofu Fang, Caryn Naekyung Kim, Charles Perkins et al. · Blood · 2000 · 260 citations · Full text
Life Sciences, Cell Biology, Pharmacology +10
Cotreatment with Histone Deacetylase Inhibitor LAQ824 Enhances Apo-2L/Tumor Necrosis Factor-Related Apoptosis Inducing Ligand-Induced Death Inducing Signaling Complex Activity and Apoptosis of Human Acute Leukemia Cells
Fei Guo, Celia Sigua, Jianguo Tao et al. · Cancer Research · 2004 · 201 citations
Life Sciences, Molecular Biology, Pharmacology +17
Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis.
Sylvie Wittmann, Purva Bali, Sreenivasa Donapaty et al. · PubMed · 2003 · 109 citations
Medicine, Oncology, Pharmacology +17
Molecular determinants of epothilone B derivative (BMS 247550) and Apo-2L/TRAIL-induced apoptosis of human ovarian cancer cells
David Griffin, Sylvie Wittmann, Fei Guo et al. · Gynecologic Oncology · 2003 · 37 citations
Life Sciences, Medicinal Chemistry, Pharmacology +17
1–5 of 6